Elite in Generalized Pustular Psoriasis (GPP)

Min H. Zheng

No. 88 Jiefang Road, 
Hangzhou, CN 
Elite in Generalized Pustular Psoriasis (GPP)
No. 88 Jiefang Road, 
Hangzhou, CN 
OverviewLocationsClinical Research

Overview

Min Zheng practices in Hangzhou, China. Zheng is rated as an Elite expert by MediFind in the treatment of Generalized Pustular Psoriasis (GPP). Their top areas of expertise are Pustular Psoriasis, Generalized Pustular Psoriasis (GPP), Psoriasis, Endoscopy, and Lithotripsy.

Their clinical research consists of co-authoring 728 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 14 articles in the study of Generalized Pustular Psoriasis (GPP).

Locations

No. 88 Jiefang Road, Hangzhou, 310009, China
Other Locations
1111 Xian Xia Road, Shanghai, 200336, China
2055 Yanan Street, Changchun, 130022, China
96 Jinzhai Road, Hefei, 230026, China
No. 739, Dingshen Road, Lincheng Street, Zhoushan, 316021, China
Dingshen Road, Lincheng Street, Zhoushan, 316021, China
No. 4, North Jianshe Road, Chengdu, 610054, China
No. 51 North You'ai Road, Nanning, 530001, China
1111XianXia Road, Shanghai, 200336, China
No. 247 Wusi Road, Fuzhou, 350003, China
8# Gong Ti South Road, Beijing, China
110, Ganhe Road, Hongkou, 200437, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period to Evaluate the Efficacy and Safety of LY2439821 in Chinese Patients With Moderate-to-Severe Plaque Psoriasis
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period to Evaluate the Efficacy and Safety of LY2439821 in Chinese Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: June 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 1, Single- and Multiple-Dose Study to Assess the Safety and Pharmacokinetics of Ixekizumab (LY2439821) (Anti-IL-17 Humanized Antibody) in Chinese Patients With Psoriasis Vulgaris
A Phase 1, Single- and Multiple-Dose Study to Assess the Safety and Pharmacokinetics of Ixekizumab (LY2439821) (Anti-IL-17 Humanized Antibody) in Chinese Patients With Psoriasis Vulgaris
Enrollment Status: Completed
Publish Date: July 22, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

727 Total Publications

Mitochondrial respiratory chain regulates HBV clearance through dual modulation of lysosomal acidification.
Mitochondrial respiratory chain regulates HBV clearance through dual modulation of lysosomal acidification.
Journal: Emerging microbes & infections
Published: October 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zheng's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 115 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile